Literature DB >> 21034950

Stomal prolapse in children with chronic intestinal pseudoobstruction: a frequent complication?

Sabine Irtan1, Marc Bellaïche, Christopher Brasher, Alaa El Ghoneimi, Jean Paul Cézard, Arnaud Bonnard.   

Abstract

AIM: The aim of the study was to evaluate the morbidity rate of stoma in children diagnosed with chronic intestinal pseudoobstruction (CIPO) and try to determine risk factors.
MATERIAL AND METHODS: Twenty-two children (65%) of 34 referred to our center between 1988 and 2008 had a stoma. They were compared with 22 other children referred for another pathology necessitating a stoma.
RESULTS: The incidence of stomal prolapse in CIPO children was 45% vs 9% in non-CIPO children (P = .01). Prolapse occurred between the first postoperative day and the 10th postoperative month, with a median of 2 months. Surgical management was required in 60%, with an intestinal necrosis rate of 20% leading to intestinal resection. No mortality was noted. No risk factors favoring prolapse in CIPO children were identified.
CONCLUSION: Children with CIPO have a high rate of stomal prolapse with an increased risk of intestinal necrosis. Careful management of the stoma is necessary to avoid the risk of intestinal resection, which may aggravate the underlying intestinal disorder.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21034950     DOI: 10.1016/j.jpedsurg.2010.06.022

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

Review 1.  Paediatric intestinal pseudo-obstruction: a scoping review.

Authors:  Susan Nham; Alexander T M Nguyen; Andrew J A Holland
Journal:  Eur J Pediatr       Date:  2022-04-28       Impact factor: 3.860

2.  Ileostomy Prolapse in Children with Intestinal Dysmotility.

Authors:  Eric A Sparks; Cristine S Velazco; Brenna S Fullerton; Jeremy G Fisher; Faraz A Khan; Amber M Hall; Tom Jaksic; Leonel Rodriguez; Biren P Modi
Journal:  Gastroenterol Res Pract       Date:  2017-09-18       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.